Shan Lu

5.2k total citations · 2 hit papers
205 papers, 3.2k citations indexed

About

Shan Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Shan Lu has authored 205 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 29 papers in Pulmonary and Respiratory Medicine and 23 papers in Infectious Diseases. Recurrent topics in Shan Lu's work include Genomics and Phylogenetic Studies (47 papers), Ferroptosis and cancer prognosis (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Shan Lu is often cited by papers focused on Genomics and Phylogenetic Studies (47 papers), Ferroptosis and cancer prognosis (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Shan Lu collaborates with scholars based in China, United States and Japan. Shan Lu's co-authors include Jianguo Xu, H. J. Yang, Dong Jin, Yulei Wang, Yinghui Guan, Xiaoyi Dai, Ji Pu, R. J. Roman, David L. Mattson and Allen W. Cowley and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Shan Lu

189 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma

2022 342 citations Yinghui Guan, Shan Lu et al. profile →
Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer

2021 206 citations Shan Lu, Yinghui Guan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shan Lu China	26	1.2k	641	527	465	433	205	3.2k
Ching‐Ping Tseng Taiwan	36	1.9k 1.6×	807 1.3×	374 0.7×	283 0.6×	320 0.7×	143	4.7k
Yue Ma China	32	1.7k 1.4×	939 1.5×	319 0.6×	203 0.4×	376 0.9×	140	3.7k
Hui‐Ling Chen Taiwan	38	1.9k 1.5×	627 1.0×	423 0.8×	327 0.7×	261 0.6×	167	4.6k
Jie Lu China	35	1.5k 1.2×	1.1k 1.8×	473 0.9×	278 0.6×	165 0.4×	169	3.7k
Joyce Carlson Sweden	31	955 0.8×	426 0.7×	442 0.8×	322 0.7×	190 0.4×	47	3.9k
Michael S. Bronze United States	34	997 0.8×	398 0.6×	376 0.7×	710 1.5×	269 0.6×	90	3.4k
Yechezkel Sidi Israel	35	1.1k 0.9×	345 0.5×	473 0.9×	410 0.9×	285 0.7×	191	3.7k
Noriko Nakajima Japan	31	987 0.8×	543 0.8×	410 0.8×	977 2.1×	348 0.8×	131	3.5k
Hans‐Peter Marti Switzerland	41	702 0.6×	291 0.5×	321 0.6×	651 1.4×	402 0.9×	187	5.7k
Libo Wang China	29	1.2k 1.0×	512 0.8×	418 0.8×	231 0.5×	770 1.8×	124	3.2k

Countries citing papers authored by Shan Lu

Since Specialization

Citations

This map shows the geographic impact of Shan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Lu more than expected).

Fields of papers citing papers by Shan Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Lu. The network helps show where Shan Lu may publish in the future.

Co-authorship network of co-authors of Shan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Lu. A scholar is included among the top collaborators of Shan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Lu. Shan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, B., Chao Liu, Bing Zhang, et al.. (2025). Discovery, total synthesis, and biological evaluation of tyrcinnamins as antibacterial agents and tyrosinase activators. European Journal of Medicinal Chemistry. 291. 117665–117665. 1 indexed citations

Wang, Zeyuan, Rui Ma, Junxia Zhang, et al.. (2025). Oestrogen-related receptor γ in sepsis-induced cardiomyopathy: role of cardiomyocyte subtype conversion. European Heart Journal.

Chen, Meilin, Zhiqi Li, Qiqi Fan, et al.. (2023). Investigation of the applicability of the zebrafish model for the evaluation of aristolochic acid-related nephrotoxicity. Phytomedicine. 121. 155092–155092. 9 indexed citations

Huang, Yuyuan, Suping Zhang, H. J. Yang, et al.. (2023). Morphological and genomic characteristics of two novel actinomycetes, Ornithinimicrobium sufpigmenti sp. nov. and Ornithinimicrobium faecis sp. nov. isolated from bat faeces (Rousettus leschenaultia and Taphozous perforates). Frontiers in Cellular and Infection Microbiology. 13. 1093407–1093407. 2 indexed citations

Wang, Ziling, Ting Wu, Le Chen, et al.. (2023). [Effect of apigenin in combination with oxymatrine on non-small cell lung cancer and mechanism].. PubMed. 48(3). 752–761. 4 indexed citations

Wang, Haojia, Chao Wu, Shan Lu, et al.. (2023). Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments. Chinese Medicine. 18(1). 7–7. 8 indexed citations

Tan, Yingying, Fanqin Zhang, Shan Lu, et al.. (2023). Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking. Chinese Medicine. 18(1). 52–52. 5 indexed citations

Liu, Yingying, Yingying Tan, Jiaqi Huang, et al.. (2022). Revealing the Mechanism of Huazhi Rougan Granule in the Treatment of Nonalcoholic Fatty Liver Through Intestinal Flora Based on 16S rRNA, Metagenomic Sequencing and Network Pharmacology. Frontiers in Pharmacology. 13. 875700–875700. 10 indexed citations

Zhu, Wentao, Yuyuan Huang, Haiyun Chen, et al.. (2022). Discovery and Evolutionary Analysis of a Novel Bat-Borne Paramyxovirus. Viruses. 14(2). 288–288. 10 indexed citations

10.

Liu, Xinkui, Meirong Bai, Huiying Li, et al.. (2022). Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer. Frontiers in Immunology. 13. 965342–965342. 11 indexed citations

11.

Liu, Fenghai, et al.. (2021). Study on the Value of DCE-MRI in Differentiating Glossitis and Tongue Cancer and the Intratumour Heterogeneity. Cancer Management and Research. Volume 13. 6925–6934. 1 indexed citations

12.

Zhang, Sihui, et al.. (2021). All five COVID-19 outbreaks during epidemic period of 2020/2021 in China were instigated by asymptomatic or pre-symptomatic individuals. SHILAP Revista de lepidopterología. 3(1). 35–40. 7 indexed citations

13.

Yang, Guangdie, Yinan Yao, Guohua Lu, et al.. (2020). Dioscin elicits anti‐tumour immunity by inhibiting macrophage M2 polarization via JNK and STAT3 pathways in lung cancer. Journal of Cellular and Molecular Medicine. 24(16). 9217–9230. 61 indexed citations

14.

Xiao-Nong, Zhou, et al.. (2018). [Remain true to our original aspiration for farewell to the God of Plague, compose the new chapter for the national schistosomiasis control programme scientifically-Commemoration of 60th anniversary of publishing Chairman Mao Zedong's two poems "Farewell to the God of Plague"].. PubMed. 30(1). 1–4. 7 indexed citations

15.

Yang, DuJiang, Huimin Lü, Qiang Guo, et al.. (2017). Timing of Laparoscopic Cholecystectomy After Mild Biliary Pancreatitis: A Systematic Review and Meta-Analysis. Journal of Laparoendoscopic & Advanced Surgical Techniques. 28(4). 379–388. 25 indexed citations

16.

Zhang, Jie, Wenrui Xu, Manman Zhao, et al.. (2016). [Clinical analysis of three cases with infant botulism and review of literature].. PubMed. 54(3). 214–7. 3 indexed citations

17.

Yang, Bao, et al.. (2016). A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment. SHILAP Revista de lepidopterología. 2 indexed citations

18.

Ryner, Lisa, Yinghui Guan, Ron Firestein, et al.. (2015). Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer. Clinical Cancer Research. 21(13). 2941–2951. 86 indexed citations

19.

Yang, Jia, et al.. (2012). Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery. SHILAP Revista de lepidopterología. 8 indexed citations

20.

Lu, Shan. (2012). New Knowledge of Rescaled Analysis Technology in the Evaluation of Fracture Development Intensity. Ground Water. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact